Skip to main content

ADVERTISEMENT

patient-centered care

Research in Review
08/15/2017
JCP Editors
A recent comparative effectiveness study examined the relationship of anticitrullinated protein antibody (ACPA) status and accrued economic burden for patients with rheumatoid arthritis, published in the Journal of...
A recent comparative effectiveness study examined the relationship of anticitrullinated protein antibody (ACPA) status and accrued economic burden for patients with rheumatoid arthritis, published in the Journal of...
A...
08/15/2017
Journal of Clinical Pathways
Research in Review
08/03/2017
JCP Editors
Single-agent immunotherapy in patients with a subtype of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) provides more clinical benefit than conventional therapy, according to research published in...
Single-agent immunotherapy in patients with a subtype of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) provides more clinical benefit than conventional therapy, according to research published in...
...
08/03/2017
Journal of Clinical Pathways
Research in Review
07/27/2017
JCP Editors
Results of a recent survey showed that for patients with cancer requiring palliative care, some symptoms and care needs are not strongly associated with specific diagnoses, published in Supportive Care in Cancer...
Results of a recent survey showed that for patients with cancer requiring palliative care, some symptoms and care needs are not strongly associated with specific diagnoses, published in Supportive Care in Cancer...
...
07/27/2017
Journal of Clinical Pathways
Research in Review
07/25/2017
JCP Editors
Human epidermal growth factor receptor 2 (HER2)-targeted therapy results in different objective response rates (ORR) across cancer types based on mutation variants, according to recent research. ----- Related...
Human epidermal growth factor receptor 2 (HER2)-targeted therapy results in different objective response rates (ORR) across cancer types based on mutation variants, according to recent research. ----- Related...
Human...
07/25/2017
Journal of Clinical Pathways
Research in Review
07/24/2017
JCP Editors
Researchers have identified five quality metrics to help improve head and neck cancer care, published in Cancer (online July 20, 2017; doi:10.1002/cncr.30902). ----- Related Content Quality Measures for NSCLC...
Researchers have identified five quality metrics to help improve head and neck cancer care, published in Cancer (online July 20, 2017; doi:10.1002/cncr.30902). ----- Related Content Quality Measures for NSCLC...
...
07/24/2017
Journal of Clinical Pathways
Research in Review
07/21/2017
JCP Editors
Terminally ill patients’ understanding of their prognosis within the last six months of their life often times remain unchanged, according to a recent study. ----- Related Content Oncology care models improve...
Terminally ill patients’ understanding of their prognosis within the last six months of their life often times remain unchanged, according to a recent study. ----- Related Content Oncology care models improve...
...
07/21/2017
Journal of Clinical Pathways
Research in Review
07/19/2017
JCP Editors
A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma (MZL), according to recent research published in Blood (online July 2017;...
A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma (MZL), according to recent research published in Blood (online July 2017;...
A new...
07/19/2017
Journal of Clinical Pathways
Research in Review
07/17/2017
JCP Editors
Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...
Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...
...
07/17/2017
Journal of Clinical Pathways
Research in Review
07/03/2017
JCP Editors
Patients with advanced melanoma who are treated with nivolumab after their first disease progression may experience tumor response without compromising safety, according to an original investigation published in JAMA...
Patients with advanced melanoma who are treated with nivolumab after their first disease progression may experience tumor response without compromising safety, according to an original investigation published in JAMA...
...
07/03/2017
Journal of Clinical Pathways
Research in Review
06/30/2017
JCP Editors
Survivors of chronic cancer are often not receiving optimal survivorship care plans and follow-up treatment, according to a study published in Cancer (published online June 27, 2017;...
Survivors of chronic cancer are often not receiving optimal survivorship care plans and follow-up treatment, according to a study published in Cancer (published online June 27, 2017;...
...
06/30/2017
Journal of Clinical Pathways